Cortical development mTOR mTORC1 mTORC2 Neural progenitor cell Radial glia Tuberous Sclerosis Complex (TSC) is a multiorgan genetic disease that prominently features brain malformations (tubers) with many patients suffering from epilepsy and autism. These malformations typically exhibit neuronal as well as glial cell abnormalities and likely underlie much of the neurological morbidity seen in TSC. Tuber pathogenesis remains poorly understood though upregulation of the mTORC1 signaling pathway in TSC has been consistently demonstrated. Here we address abnormal brain development in TSC by inactivating the mouse Tsc1 gene in embryonic neural progenitor cells. This strategy permits evaluation of the role of the Tsc1 gene in both neuronal as well as glial cell lineages. Tsc1
Tuberous Sclerosis Complex (TSC) is a multiorgan genetic disease that prominently features brain malformations (tubers) with many patients suffering from epilepsy and autism. These malformations typically exhibit neuronal as well as glial cell abnormalities and likely underlie much of the neurological morbidity seen in TSC. Tuber pathogenesis remains poorly understood though upregulation of the mTORC1 signaling pathway in TSC has been consistently demonstrated. Here we address abnormal brain development in TSC by inactivating the mouse Tsc1 gene in embryonic neural progenitor cells. This strategy permits evaluation of the role of the Tsc1 gene in both neuronal as well as glial cell lineages. Tsc1
Emx1-Cre conditional knockout (CKO) animals die by 25 days of life. Their brains have increased size and contain prominent large cells within the cerebral cortex that have greatly increased mTORC1 signaling and decreased mTORC2 signaling. Severe defects of cortical lamination, enlarged dysmorphic astrocytes and decreased myelination were also found. Tsc1 Emx1-Cre CKO mice were then treated with rapamycin to see if the premature death and brain abnormalities can be rescued. Postnatal rapamycin treatment completely prevented premature death and largely reversed the glia pathology but not abnormal neuronal lamination. These findings support a model that loss of function of the TSC genes in embryonic neural progenitor cells causes cortical malformations in patients with TSC. The dramatic effect of rapamycin suggests that even with extensive multi-lineage abnormalities, a postnatal therapeutic window may exist for patients with TSC. © 2011 Elsevier Inc. All rights reserved.
Introduction
Tuberous Sclerosis Complex (TSC) is a relatively common genetic disorder that affects approximately 1:6,000 individuals worldwide (Crino et al., 2006) . While inheritable as an autosomal dominant disorder, the majority of patients with TSC have spontaneous mutations in either the TSC1 gene (encodes hamartin) or TSC2 gene (encodes tuberin). Loss of function of either gene can lead to the full clinical spectrum of TSC though individuals with TSC2 inactivation tend to have more severe disease manifestations (Dabora et al., 2001; Ess, 2009; Jones et al., 1999; Sancak et al., 2005) . While TSC impacts multiple organs; brain manifestations are especially debilitating due to a very high prevalence of epilepsy, developmental delay, autism and mental retardation (Rosser et al., 2006) . These clinical features are generally ascribed to the presence of extensive focal brain malformations (tubers) that are found predominantly in the cortex of these patients. Pathological analyses of tubers show severe disruption of cortical layers and prominent "giant" cells that express markers of both neuronal and glia lineages (Ess et al., 2005; Mizuguchi and Takashima, 2001 ). These findings suggest that they may result from abnormal differentiation of neural progenitor cells. Much progress has been made during the last decade in determining the function(s) of hamartin and tuberin, including roles in cellular proliferation, cell size determination and control of apoptosis. Specific actions of hamartin are not well understood but may regulate cellular adhesion through control of the GTPase Rho (Lamb et al., 2000) . In contrast, tuberin function has been extensively studied with the identification of multiple upstream and downstream signaling pathways that converge upon this protein. These include inactivation by Akt and activation by AMPK (Inoki et al., 2003; Kwiatkowski, 2003) . The most highly conserved region in tuberin is the GTPase activating protein (GAP) domain. This domain is required for inactivation of the small G protein Rheb (Ras homolog enriched in brain) that in turn is an activator of the serine/threonine kinase mTOR. mTOR functions within two distinct multiprotein complexes, mTORC1 and mTORC2. mTORC1 contains mTOR, raptor and mLST8 and controls mRNA translation by phosphorylation of ribosomal S6-kinase and 4E-BP1 (Inoki et al., 2005) . In contrast, mTORC2 contains mTOR, rictor and mLST8. mTORC2 function is much less understood but appears to be involved in cytoskeleton organization as well as Neurobiology of Disease 45 (2012) 369-380 
